Latest ownership filings
SC 13D/A
Akero Therapeutics, Inc.
15 Sep 22
SC 13G/A
Checkmate Pharmaceuticals, Inc.
7 Jun 22
4
COREY S GOODMAN
17 May 22
4
COREY S GOODMAN
12 May 22
4
COREY S GOODMAN
9 May 22
SC 13G/A
Checkmate Pharmaceuticals, Inc.
5 May 22
4
COREY S GOODMAN
4 May 22
4
COREY S GOODMAN
29 Apr 22
4
COREY S GOODMAN
26 Apr 22
4
COREY S GOODMAN
21 Apr 22
SC 13G/A
Harmony Biosciences Holdings, Inc.
14 Feb 22
SC 13D/A
Akero Therapeutics, Inc.
7 May 21
SC 13G
IMPEL NEUROPHARMA INC
7 May 21
4
COREY S GOODMAN
29 Apr 21
4
COREY S GOODMAN
26 Apr 21
3
COREY S GOODMAN
22 Apr 21
SC 13G
Harmony Biosciences Holdings, Inc.
16 Feb 21
SC 13G
Checkmate Pharmaceuticals, Inc.
6 Oct 20
SC 13D
ALX ONCOLOGY HOLDINGS INC
1 Oct 20
SC 13D/A
Akero Therapeutics, Inc.
9 Sep 20
4
COREY S GOODMAN
12 Aug 20
3
COREY S GOODMAN
6 Aug 20
4
Robert J Adelman
21 Jul 20
3
Robert J Adelman
16 Jul 20
4
Robert J Adelman
6 Jul 20
SC 13D/A
Menlo Therapeutics Inc.
16 Apr 20
4
Robert J Adelman
6 Mar 20
4
COREY S GOODMAN
3 Mar 20
4
Robert J Adelman
27 Feb 20
4
Robert J Adelman
12 Feb 20
4
COREY S GOODMAN
10 Feb 20
4
Robert J Adelman
6 Feb 20
SC 13D/A
Akero Therapeutics, Inc.
15 Jan 20
4
Robert J Adelman
14 Jan 20
4
Robert J Adelman
10 Jan 20
4
Robert J Adelman
8 Jan 20
4
COREY S GOODMAN
6 Jan 20
4
Robert J Adelman
3 Jan 20
SC 13D
Akero Therapeutics, Inc.
26 Jun 19
4
COREY S GOODMAN
25 Jun 19